Efficacy of Platelet and Plasma Transfusion During Modified Ultra Filtration Using Neonatal CPB and Blood Viscosity Test (TEG6s)

Efficacy of Platelet and Plasma Transfusion During Modified Ultra Filtration Using Neonatal Cardiopulmonary bypass and Blood Viscosity Test (TEG6s)

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1012240014

Enrollment

Registered

2024-06-11

Start date

2024-06-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital heart disease Thrombelastography

Interventions

Transfusing fresh frozen plasma and platelet concentrate during Modified Ultrafiltration.

D010949

Fresh Frozen Plasma, platelet concentrate

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Neonatal Cases Requiring CPB

Exclusion criteria

Exclusion criteria: crinical confounder including emergency case or massive bleeding etc

Design outcomes

Primary

Measure	Time frame
Bleeding volume	—

Secondary

Measure	Time frame
Operating time, Transfusion Volume , CFF, CRT	—

Contacts

Public ContactOgasawara Yuki

Hokkaido Medical Center for Child Health and Rehabilitation

yuki.ogasawara8091@gmail.com+81-11-691-5696

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026